Nexalin Technology (NXL) EBITDA (2021 - 2026)

Nexalin Technology's EBITDA history runs 6 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• In Q1 2026, EBITDA fell 5.5% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$8.3 million (up 2.61% YoY), while the FY2025 annual figure was -$8.2 million, down 8.07% from the prior year.
• EBITDA was -$2.1 million for Q1 2026 at Nexalin Technology, up from -$2.4 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$135401.0 in Q3 2022 to a low of -$2.8 million in Q4 2024.
• Historically, EBITDA has averaged -$1.4 million across 5 years, with a median of -$1.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: EBITDA jumped 92.46% in 2022, then sank 1620.43% in 2023.
• A 5-year view of EBITDA shows it stood at -$693364.0 in 2022, then retreated by 12.77% to -$781874.0 in 2023, then tumbled by 262.39% to -$2.8 million in 2024, then rose by 16.16% to -$2.4 million in 2025, then grew by 11.73% to -$2.1 million in 2026.
• The last three EBITDA figures came in at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.